Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism LRRK2 G2019S inhibitors(LRRK2 G2019S inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC23H29N5O |
InChIKeyOXKGTOAHTYULQD-IVGNWBEBSA-N |
CAS Registry3054889-69-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Discovery | United States | 13 Feb 2025 | |
Parkinson Disease | Discovery | United States | 13 Feb 2025 |